Answers are grounded in this paper and cite their sources.
Fractalkine (FKN) is a unique cell surface protein with potential as a therapeutic target because of its role in inflammatory diseases and cancer. We developed an aptamer, named FKN-S2, with a dissociation constant of 3.4 ± 0.7 nM that is specific to the chemokine domain of fractalkine.
No takes yet. Share an insight, caveat, or question.
Waybrant et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: